Follow
Kamil Kuca
Title
Cited by
Cited by
Year
Redox-and non-redox-metal-induced formation of free radicals and their role in human disease
M Valko, K Jomova, CJ Rhodes, K Kuča, K Musílek
Archives of toxicology 90 (1), 1-37, 2016
7382016
The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview
Q Wu, L Liu, A Miron, B Klímová, D Wan, K Kuča
Archives of toxicology 90 (8), 1817-1840, 2016
3682016
Condensed and hydrolysable tannins as antioxidants influencing the health
V Koleckar, K Kubikova, Z Rehakova, K Kuca, D Jun, L Jahodar, L Opletal
Mini reviews in medicinal chemistry 8 (5), 436-447, 2008
3502008
Biological degradation of aflatoxins
Q Wu, A Jezkova, Z Yuan, L Pavlikova, V Dohnal, K Kuca
Drug metabolism reviews 41 (1), 1-7, 2009
3302009
Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine
F Zemek, L Drtinova, E Nepovimova, V Sepsova, J Korabecny, J Klimes, ...
Expert opinion on drug safety 13 (6), 759-774, 2014
2782014
Structural requirements of acetylcholinesterase reactivators
K Kuca, D Jun, K Musilek
Mini reviews in medicinal chemistry 6 (3), 269-277, 2006
2622006
Insect antimicrobial peptides, a mini review
Q Wu, J Patočka, K Kuča
Toxins 10 (11), 461, 2018
2432018
Oxidative stress-mediated cytotoxicity and metabolism of T-2 toxin and deoxynivalenol in animals and humans: an update
QH Wu, X Wang, W Yang, AK Nüssler, LY Xiong, K Kuča, V Dohnal, ...
Archives of toxicology 88 (7), 1309-1326, 2014
2162014
Acetylcholinesterase and butyrylcholinesterase–important enzymes of human body
J Patočka, K Kuča, D Jun
Acta Medica (Hradec Kralove) 47 (4), 215-228, 2004
2122004
Metabolic pathways of trichothecenes
Q Wu, V Dohnal, L Huang, K Kuča, Z Yuan
Drug metabolism reviews 42 (2), 250-267, 2010
2092010
Metabolism of aflatoxins: key enzymes and interindividual as well as interspecies differences
V Dohnal, Q Wu, K Kuča
Archives of toxicology 88 (9), 1635-1644, 2014
1982014
Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction
J Bajgar, J Fusek, K Kuca, L Bartosova, D Jun
Mini reviews in medicinal chemistry 7 (5), 461-466, 2007
1742007
Multitarget drug design strategy: quinone–tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects
E Nepovimova, E Uliassi, J Korabecny, LE Pena-Altamira, S Samez, ...
Journal of medicinal chemistry 57 (20), 8576-8589, 2014
1632014
Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase
K Kuča, J Bielavský, J Cabal, J Kassa
Bioorganic & medicinal chemistry letters 13 (20), 3545-3547, 2003
1622003
Consequences of chronic diseases and other limitations associated with old age–a scoping review
P Maresova, E Javanmardi, S Barakovic, J Barakovic Husic, S Tomsone, ...
BMC public health 19 (1), 1-17, 2019
1572019
Alzheimer’s disease and language impairments: social intervention and medical treatment
B Klimova, P Maresova, M Valis, J Hort, K Kuca
Clinical interventions in aging 10, 1401, 2015
1562015
Socio-economic aspects of Alzheimer's disease
P Maresova, H Mohelska, J Dolejs, K Kuca
Current Alzheimer Research 12 (9), 903-911, 2015
1492015
Specification of the structure of oximes able to reactivate tabun‐inhibited acetylcholinesterase
J Cabal, K Kuča, J Kassa
Basic & clinical pharmacology & toxicology 95 (2), 81-86, 2004
1492004
Assessment of acetylcholinesterase activity using indoxylacetate and comparison with the standard Ellman’s method
M Pohanka, M Hrabinova, K Kuca, JP Simonato
International journal of molecular sciences 12 (4), 2631-2640, 2011
1482011
A comparison of the ability of a new bispyridinium oxime—1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium) butane dibromide and currently used oximes to reactivate …
K Kuča, J Kassa
Journal of enzyme inhibition and medicinal chemistry 18 (6), 529-535, 2003
1462003
The system can't perform the operation now. Try again later.
Articles 1–20